Dealings in securities by a director of a major subsidiary
LIFE HEALTHCARE GROUP HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 2003/002733/06)
ISIN: ZAE000145892
JSE and A2X share code: LHC
(“Life Healthcare” or “the Company”)
LIFE HEALTHCARE FUNDING LIMITED
(Incorporated in the Republic of South Africa with limited liability)
Registration number: 2016/273566/06
Bond company code: LHFI
("Life Healthcare Funding")
DEALINGS IN SECURITIES BY A DIRECTOR OF A MAJOR SUBSIDIARY
In compliance with the JSE Listings Requirements, Life Healthcare shareholders are hereby advised of
the following dealings in securities by the Chief Executive Officer – SA, Adam Pyle, a director of a major
subsidiary of the Company.
The details of which are as follows:
Name of director : Adam Pyle
Name of Company : Life Healthcare Group Proprietary Limited
Nature of transaction : On market purchase of shares
Date of transaction : 30 November 2022
Number of securities : 43 350
Class of securities : Ordinary shares
Total value of transaction : R745 841.09
Purchase price per share : R17.21
Nature of interest : Direct beneficial
Clearance obtained : Yes
Dunkeld
1 December 2022
Equity Sponsor and Debt Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)
Date: 01-12-2022 04:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.